Graves'
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who were referred to Division of Nuclear Medicine, Faculty of Medicine Siriraj Hospital for the first radioactive iodine treatment for Graves' disease 2. Stop antithyroid drugs 5-7 days prior to administration of radioactive iodine
Exclusion criteria
Exclusion criteria: 1. Previously treated with radioactive iodine treatment or thyroidectomy 2. Required a radioactive iodine dose of more than 150 microcuries per 1 gram of thyroid tissue 3. Pregnant or lactating women 4. Not voluntarily agree to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success of radioactive iodine treatment for Graves' disease At 6 months after radioactive iodine treatment Ability to discontinue antithyroid drugs | — |
Secondary
| Measure | Time frame |
|---|---|
| Factors associated with success of radioactive iodine treatment for Graves' disease At 6 months after radioactive iodine treatment Determination of factors associated with success of radioactive iodine treatment for Graves' disease | — |
Countries
Thailand
Contacts
Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand